Aspirin to prevent ppregnancy-induced hypertension

Zvi Herschman, Ari Klapholz, Eyal Schiff, Shlomo Mashiach

Research output: Contribution to journalLetterpeer-review

2 Scopus citations


To the Editor: The report by Schiff et al. (Aug. 10 issue)* regarding the prevention of ppregnancy-induced hypertension through the use of low-dose aspirin is very exciting. As the authors state, aspirin has effects on thromboxane production as well as platelet function in general. In their study, 14.7 percent of the women in the treated group had cesarean deliveries, as compared with 29.0 percent in the placebo group and 10.6 percent in the low-risk control group. Anticipating the widespread use of this therapy and knowing its effects on platelets and the risks of transfusion, we would be very interested in.

Original languageEnglish
Pages (from-to)204-205
Number of pages2
JournalNew England Journal of Medicine
Issue number3
StatePublished - 18 Jan 1990
Externally publishedYes


Dive into the research topics of 'Aspirin to prevent ppregnancy-induced hypertension'. Together they form a unique fingerprint.

Cite this